The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract for $14,887.50 to Parse Biosciences, Inc., a for-profit manufacturer of biotechnology products and services. The contract, which does not have a set-aside designation, is for the delivery of reagents to support single-cell RNA and T-cell receptor (TCR) sequencing of secondary hemophagocytic lymphohistiocytosis (sHLH), an inflammatory condition. This contract award is in support of NIAID's broader research efforts to advance the understanding and treatment of infectious diseases.
Generated 8/27/24, 10:04 AM